How I can help your business

• Guide you through trade mark, design, patent and regulatory disputes, including litigation before the English Courts and UPC Local and Central Divisions.
• Advise on compliance with clinical trials legislation and pharmaceutical data and marketing exclusivity.
• Advise on developing, acquiring and monetising IP assets, including assisting in negotiations with partners and the drafting of commercial agreements.

Overview & Expertise

Marcus is a Managing Associate and solicitor based in London at Marks & Clerk. He advises on a wide range of intellectual property matters, with a particular focus on patent litigation in the biotechnology and pharmaceutical sectors. Over recent years, Marcus has represented a range of clients in multi-jurisdictional and technically complex disputes in the English Courts and the UPC Local and Central Divisions, often working with legal teams across Europe and North America to co-ordinate litigation strategies. Marcus also has experience in representing clients in settlement negotiations and has assisted clients in resolving disputes on terms both pre-litigation and pre-trial.

Alongside his contentious practice, Marcus advises clients (ranging from start-ups to multinational organisations) across a variety of sectors in relation to developing, acquiring and monetising IP assets. In this regard, Marcus has experience in advising on, negotiating and drafting a broad range of commercial agreements. 

On the regulatory front, Marcus has advised on compliance with clinical trials legislation and pharmaceutical data and marketing exclusivity, as well as freedom of information and data protection matters.

Before moving into law, Marcus worked for five years in pharmaceutical market research, developing and managing national and international projects in various medical fields, working closely with medical practitioners and client business units. This experience, combined with Marcus’ biotechnology and genetics background, allows him to quickly grasp the key technical and commercial issues of disputes and transactions seen in science-based industries.

Marcus trained and qualified as a solicitor at a leading international law firm and joined Marks & Clerk in September 2016.

Client Work & Case Experience

Regeneron v Kymab Limited & Novo Nordisk (High Court)

Blue Bio v Secretary of State for Health (High Court)

International Stem Cell v Comptroller General of Patents (CJEU)

Unwired Planet v Huawei (High Court)

Fujifilm Kyowa Kirin Biologics v AbbVie (High Court & Court of Appeal)

Chugai v UCB (High Court)

Pfizer v Roche (High Court)

Greencastle v Payne and Others (IPEC)

Teva & Regeneron v Pfizer (High Court)

Pfizer v GSK & ID Biomedical (High Court)

Pfizer v GSK (UPC, Milan Central Division)

GSK v Pfizer (UPC, Düsseldorf Local Division)

AstraZeneca v Hansoh (High Court)